/PRNewswire/ DXVX announces that its affiliated company Oxford Vacmedix (OVM) has completed Phase 1a trial of cancer vaccine and plans to proceed Phase 1b.
Notwithstanding the weakness this year, Korea Fund has been a long-standing source of alpha for investors. Click here to read what investors need to know.
THINK Surgical and Curexo Announce Entry Into Development and Distribution Agreement apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.